AgelessRx vs InstaRX
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
AgelessRx
Best for longevity-focused GLP-1 care (pending verification)Starting at $199/mo
InstaRX
Best for Patients in any of the 50 states or DC seeking a multi-product compounded-medication telehealth platform (GLP-1 + peptides + sexual health) where they prefer to complete an intake to see pricing rather than comparing public per-dose tiers. NOT recommended for patients who require transparent upfront pricing, named pharmacy-partner disclosure, or visible LegitScript/HIPAA accreditation before committing to an intake.Starting at $199/mo
Side-by-Side Comparison
| Feature | AgelessRx | InstaRX |
|---|---|---|
| Overall Score | ✓7.1/10 | 6.8/10 |
| Starting Price | $199/mo | $199/mo |
| Editorial Rating | ✓3.6 ★ /5 | 3.4 ★ /5 |
| Features | 6 features | ✓10 features |
| States Available | 0 | ✓51 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
AgelessRx
Pros
- ✓Established brand based in Ann Arbor, MI with US-licensed providers
- ✓Offers both compounded and brand-name (Wegovy) options
- ✓Longevity-first positioning — patients get a broader metabolic health framing vs single-condition GLP-1 funnels
- ✓Listed in both competitor directories
Cons
- ✗Stub entry — pricing, states served, and GLP-1-specific intake workflow need YMYL verification
- ✗Confidence LOW until verified
- ✗Longevity-first positioning means GLP-1 is one of several products — patients looking specifically for GLP-1 care may be funneled into a broader longevity intake
InstaRX
Pros
- ✓All 50 states + DC coverage (per public FAQ: 'InstaRX is available in all 50 states and the District of Columbia')
- ✓Multi-product platform — patients can manage GLP-1 + anti-aging peptides + sexual-health medications on one account
- ✓Compounded semaglutide AND compounded tirzepatide both offered
- ✓Independent third-party provider group (Dr Telx) is named in the Terms of Service — partial transparency
Cons
- ✗No per-dose, monthly, or subscription pricing disclosed publicly — only 'Get Started For Just $199' marketing hook; patients cannot compare costs without completing an intake
- ✗No LegitScript badge, HIPAA seal, or NABP accreditation displayed on public-facing pages
- ✗No compounding-pharmacy partner named on public-facing pages (the site only states 'compounded GLP-1s exclusively from U.S. pharmacies')
- ✗Terms of Service is generic boilerplate (the language 'consultations limited to diagnosis and treatment of certain women's health issues' appears to be a copy-paste error from a women's health platform — suggests low template hygiene)
- ✗Delaware governing law for arbitration disputes — typical telehealth platform structure but offers no California consumer protections despite the Huntington Beach corporate address
- ✗Corporate address is a strip-mall suite (15061 Springdale St. Suite 206, Huntington Beach, CA) — suggests pure-virtual operation without clinical or pharmacy infrastructure on-site
Our Verdict
AgelessRx edges out InstaRX with a higher overall score of 7.1/10 and is particularly strong for longevity-focused GLP-1 care (pending verification). InstaRX remains a solid alternative, especially if you're looking for Patients in any of the 50 states or DC seeking a multi-product compounded-medication telehealth platform (GLP-1 + peptides + sexual health) where they prefer to complete an intake to see pricing rather than comparing public per-dose tiers. NOT recommended for patients who require transparent upfront pricing, named pharmacy-partner disclosure, or visible LegitScript/HIPAA accreditation before committing to an intake..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.